Concepedia

Haoheng Yan

HY

Statistics

Publications

20

Citations

1.2K

H-Index

18

Active since

2006

Affiliations

Bristol-Myers Squibb (United States)(Current)

University of Massachusetts Amherst

Pfizer (United States)

GlaxoSmithKline (United States)

Takeda (United States)

Haoheng Yan is an author at Bristol-Myers Squibb (United States) specializing in pharmacy, biopharmaceutics, and bioanalytical method validation.

Publications per year

2006–2023

20

Publications

20

Protein-passivated Fe3O4 nanoparticles: low toxicity and rapid heating for thermal therapy

Bappaditya Samanta, Haoheng Yan, Nicholas O. Fischer et al. · Journal of Materials Chemistry · 2008 · 190 citations · Full text

, , +17

A Genome-wide siRNA Screen Identifies Proteasome Addiction as a Vulnerability of Basal-like Triple-Negative Breast Cancer Cells

Fabio Petrocca, Gabriel Altschuler, Shen Mynn Tan et al. · Cancer Cell · 2013 · 172 citations · Full text

, , +10

Multi-Attribute Method for Quality Control of Therapeutic Proteins

Sarah Rogstad, Haoheng Yan, Xiaoshi Wang et al. · Analytical Chemistry · 2019 · 115 citations

, , +16

2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 – Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62)

Steven P. Piccoli, Devangi Mehta, Alessandra Vitaliti et al. · Bioanalysis · 2019 · 95 citations · Full text

, , +13

Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4 nanoparticles

Avinash Bajaj, Bappaditya Samanta, Haoheng Yan et al. · Journal of Materials Chemistry · 2009 · 76 citations · Full text

, , +17

1–5 of 20